# European oncology center accreditations

> Developing situation record from CLSTR: https://clstr.news/situations/european-oncology-center-accreditations
> Updated: 2026-10-26T12:23:16.000Z. Sources: 2. Developments: 2.

European cancer institutions have received high-level recognitions from major medical organizations. 

In late September 2026, the Organisation of European Cancer Institutes (OECI) granted the ‘Comprehensive Cancer Centre with Research Excellence’ designation to INOC in Italy and Maastricht UMC+ in the Netherlands. This classification is reserved for institutions that integrate clinical care, scientific research, and innovation according to European quality standards.

Following this, the Portuguese Institute of Oncology of Coimbra Francisco Gentil (IPO de Coimbra) received recognition from the European Society for Medical Oncology (ESMO). Designated as an ‘ESMO Designated Centre of Integrated Oncology and Palliative Care’ for the 2027–2029 period, the institution was recognized for its person-centered approach that combines oncological treatments with palliative care.

## Timeline

### 2026-10-26: IPO de Coimbra receives European oncology distinction

The Portuguese Institute of Oncology of Coimbra has been named an ESMO Designated Centre of Integrated Oncology and Palliative Care for 2027-2029.

2 sources. https://clstr.news/cluster/ipo-de-coimbra-receives-european-oncology-distinction

### 2026-09-29: European cancer centers INOC and Maastricht UMC+ receive top OECI designation

INOC and Maastricht UMC+ have received the highest OECI designation, ‘Comprehensive Cancer Centre with Research Excellence’, recognizing their integration of clinical care and scientific research.

2 sources. https://clstr.news/cluster/european-cancer-centers-inoc-and-maastricht-umc-receive-top-oeci-designation

---
Cite as: European oncology center accreditations. CLSTR, https://clstr.news/situations/european-oncology-center-accreditations
